Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction

This publication has 27 references indexed in Scilit:

• Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction
  The American Journal of Cardiology, 1996
• A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1995
• Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris
  The American Journal of Cardiology, 1995
• Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.
  Heart, 1995
• Platelet aggregability in vivo is attenuated byverapamil but not bymetoprolol in patients with stable angina pectoris
  The American Journal of Cardiology, 1995
• Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction
  The American Journal of Cardiology, 1993
• Secondary prevention with verapamil after myocardial infarction
  The American Journal of Cardiology, 1990
• Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
  The American Journal of Cardiology, 1990
• Effects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris
  The American Journal of Cardiology, 1990
• Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)
  The American Journal of Cardiology, 1990